Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
USF1 deficiency activates brown adipose tissue and improves cardiometabolic health.
Laurila PP, Soronen J, Kooijman S, Forsström S, Boon MR, Surakka I, Kaiharju E, Coomans CP, Van Den Berg SA, Autio A, Sarin AP, Kettunen J, Tikkanen E, Manninen T, Metso J, Silvennoinen R, Merikanto K, Ruuth M, Perttilä J, Mäkelä A, Isomi A, Tuomainen AM, Tikka A, Ramadan UA, Seppälä I, Lehtimäki T, Eriksson J, Havulinna A, Jula A, Karhunen PJ, Salomaa V, Perola M, Ehnholm C, Lee-Rueckert M, Van Eck M, Roivainen A, Taskinen MR, Peltonen L, Mervaala E, Jalanko A, Hohtola E, Olkkonen VM, Ripatti S, Kovanen PT, Rensen PC, Suomalainen A, Jauhiainen M. Laurila PP, et al. Among authors: jula a. Sci Transl Med. 2016 Jan 27;8(323):323ra13. doi: 10.1126/scitranslmed.aad0015. Sci Transl Med. 2016. PMID: 26819196
Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey.
Sipilä K, Moilanen L, Nieminen T, Reunanen A, Jula A, Salomaa V, Kaaja R, Kukkonen-Harjula K, Lehtimäki T, Kesäniemi YA, Koivistoinen T, Nieminen MS, Tuomilehto J, Kähönen M. Sipilä K, et al. Among authors: jula a. Atherosclerosis. 2009 May;204(1):276-81. doi: 10.1016/j.atherosclerosis.2008.08.029. Epub 2008 Sep 4. Atherosclerosis. 2009. PMID: 18848324
High prevalence of four long QT syndrome founder mutations in the Finnish population.
Marjamaa A, Salomaa V, Newton-Cheh C, Porthan K, Reunanen A, Karanko H, Jula A, Lahermo P, Väänänen H, Toivonen L, Swan H, Viitasalo M, Nieminen MS, Peltonen L, Oikarinen L, Palotie A, Kontula K. Marjamaa A, et al. Among authors: jula a. Ann Med. 2009;41(3):234-40. doi: 10.1080/07853890802668530. Ann Med. 2009. PMID: 19160088 Free PMC article.
OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism.
Perttilä J, Merikanto K, Naukkarinen J, Surakka I, Martin NW, Tanhuanpää K, Grimard V, Taskinen MR, Thiele C, Salomaa V, Jula A, Perola M, Virtanen I, Peltonen L, Olkkonen VM. Perttilä J, et al. Among authors: jula a. J Mol Med (Berl). 2009 Aug;87(8):825-35. doi: 10.1007/s00109-009-0490-z. Epub 2009 Jun 25. J Mol Med (Berl). 2009. PMID: 19554302 Free PMC article.
Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis.
Luotola K, Pääkkönen R, Alanne M, Lanki T, Moilanen L, Surakka I, Pietilä A, Kähönen M, Nieminen MS, Kesäniemi YA, Peters A, Jula A, Perola M, Salomaa V; Health 2000 AIRGENE Study Groups. Luotola K, et al. Among authors: jula a. J Clin Endocrinol Metab. 2009 Nov;94(11):4575-83. doi: 10.1210/jc.2009-0666. Epub 2009 Oct 9. J Clin Endocrinol Metab. 2009. PMID: 19820020
European lactase persistence genotype shows evidence of association with increase in body mass index.
Kettunen J, Silander K, Saarela O, Amin N, Müller M, Timpson N, Surakka I, Ripatti S, Laitinen J, Hartikainen AL, Pouta A, Lahermo P, Anttila V, Männistö S, Jula A, Virtamo J, Salomaa V, Lehtimäki T, Raitakari O, Gieger C, Wichmann EH, Van Duijn CM, Smith GD, McCarthy MI, Järvelin MR, Perola M, Peltonen L. Kettunen J, et al. Among authors: jula a. Hum Mol Genet. 2010 Mar 15;19(6):1129-36. doi: 10.1093/hmg/ddp561. Epub 2009 Dec 16. Hum Mol Genet. 2010. PMID: 20015952 Free PMC article.
Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes.
Luotola K, Pietilä A, Alanne M, Lanki T, Loo BM, Jula A, Perola M, Peters A, Zeller T, Blankenberg S, Salomaa V; Health 2000, FINRISK97, and AIRGENE Study Groups. Luotola K, et al. Among authors: jula a. Metabolism. 2010 Oct;59(10):1520-7. doi: 10.1016/j.metabol.2010.01.017. Epub 2010 Feb 23. Metabolism. 2010. PMID: 20178882
446 results